International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 8.12.2021
researcher in lab
covid-19 booster shots
The New World of the COVID-19 Delta Variant
Myeloma patients must take extra precautions to stay safe from COVID-19 infection, especially with the emergence of the Delta variant, says IMF Chairman Dr. Brian G.M. Durie. FDA authorization of a booster shot for the immunocompromised is expected shortly.
2020BlogButton.png
patient family webinar with speakers
Register for the IMF Patient and Family Webinar on August 14
The next IMF Patient and Family Webinar will take place on Saturday, August 14, at 10 a.m. PT / 1 p.m. ET. IMF Chairman Dr. Brian G.M. Durie will moderate presentations with the myeloma experts Rafat Abonour, MD (Indiana University School of Medicine — Indianapolis); Noopur Raje, MD (Massachusetts General Hospital — Boston); and Kevin Brigle PhD, ANP (Virginia Commonwealth University, Massey Cancer Center — Richmond, VA). Join us to hear about Myeloma 101, COVID-19, approaches to relapse, and more!
register button
Living Well Financial Support Webinar headshots
Register for the Living Well with Myeloma Webinar on August 12
The next “Living Well with Myeloma” webinar will take place at 4 p.m. PT / 7 p.m. ET on Thursday, August 12. During the webinar, myeloma patients and their caregivers will learn how to access physical support services, financial resources, and more. The speakers include IMF Nurse Leadership Board member Beth Faiman PhD, MSN, APRN-BC, AOCN®, FAAN; Oncology Social Worker Rebecca Zeiter, MSSA, LSW; and Financial Navigator Shontia Gamble, LSW. All the speakers are practicing in their fields at the Cleveland Clinic Taussig Cancer Institute. The panel will discuss commonly encountered financial and other considerations that patients and caregivers may face.
register button
Best of ASCO 2021 Webinar Replay banner
Watch a Replay of the Best of ASCO / EHA Webinar
What’s new in myeloma research? In this webinar, IMF Chairman Dr. Brian G.M. Durie discusses important new findings from the 2021 American Society of Clinical Oncology (ASCO) annual meeting that took place virtually from June 4-8 this year, and from the subsequent European Hematology Association’s (EHA) annual meeting. Dr. Durie explains this data in approachable terms that patients and caregivers can use in their everyday care decision-making.
2020WatchNowButton.png
angela barto with son and husband
Donate to the Angela Dirks Barto Memorial Golf Tournament
Angela Dirks Barto, who lost her battle with myeloma at the age of 44, is pictured here with her husband and son. To honor her memory, Angela’s loved ones are hosting a memorial golf tournament on Sunday, August 15, at 1 p.m. ET with the hope of supporting an IMF Research Grant. While the event itself is sold-out, the team is halfway to their goal, with donations and sponsorships still greatly needed. Help Angela’s team reach their goal today.
donate_Button2.png
hatfield hike banner
On the Home Stretch: Bill Hatfield Hikes the Appalachian Trail to Raise Funds to Find a Cure for Myeloma
Bill Hatfield returned to hiking the Appalachian Trail on April 17, 2021, to raise funds for the International Myeloma Foundation (IMF) along the way. The IMF is immensely grateful to Bill for his 2,200-mile journey on foot, which will reach its end on September 11, 2021. Over the course of the next month, Bill asks that you cheer his Australian cattle dog Huckleberry and him to the end of the Appalachian Trail, and if you can, donate to the IMF.
donate_Button2.png
facon maia eha presentation
Watch This Video from EHA 2021 on the MAIA Study
In this video, Dr. Thierry Facon (Lille University Hospital Lille, France) discusses the results of the MAIA study, which compared the overall survival results in transplant-ineligible newly diagnosed multiple myeloma patients using daratumumab, lenalidomide, and dexamethasone versus those using lenalidomide and dexamethasone alone.
2020WatchNowButton.png
490x245NovisGrant.png
Calling All Researchers: Submit Your Grant Applications
The Brian D. Novis Research Grants honor IMF founder Brian Novis, who succumbed to multiple myeloma in July of 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The 2022 grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. The deadline to submit the applications is October 1, 2021. 
2020ButtonApplyNow.png
ask doctor durie video image
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

Can myeloma maintenance therapy be adjusted? 
Watch Now
 
Clinical Trial Fact Sheets

Smart Patients: Join the Conversation

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)
Events
Register Now
Miracles for Myeloma Virtual Run/Walk

Watch the Replay
“Living Well with Myeloma” Webinar on Nutrition

Watch the Replay
M-Power Charlotte Community Workshop

Click here to see all events
 

We Thank Our Sponsors:

Amgen, Bristol Myers Squibb, Karyopharm Therapeutics, Oncopeptides Inc.,
Sanofi-Genzyme, and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
2020ButtonDonateBurg.png
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma

www.myeloma.org
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
1-800-452-2873
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page